Menu
Search
|

Menu

Close
X

Coloplast A/S COLOB.CO (Copenhagen Stock Exchange)

704.00 DKK
-3.80 (-0.54%)
As of Mar 18
chart
Previous Close 707.80
Open 707.80
Volume 204,406
3m Avg Volume 264,263
Today’s High 708.40
Today’s Low 701.80
52 Week High 716.60
52 Week Low 496.00
Shares Outstanding (mil) 198.00
Market Capitalization (mil) 140,144.41
Forward P/E 38.59
Dividend (Yield %) 11.00 ( 2.26 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.89 Mean rating from 19 analysts

KEY STATS

Revenue (mm, DKK)
FY19
4,321
FY18
16,449
FY17
15,528
FY16
14,681
EPS (DKK)
FY19
4.666
FY18
18.101
FY17
17.860
FY16
14.813
*Note: Units in Millions of Danish Krone
**Note: Units in Danish Krone

KEY RATIOS

Price to Earnings (TTM)
vs sector
38.59
40.53
Price to Sales (TTM)
vs sector
8.33
8.82
Price to Book (MRQ)
vs sector
28.96
4.66
Price to Cash Flow (TTM)
vs sector
31.01
28.75
Total Debt to Equity (MRQ)
vs sector
60.42
17.43
LT Debt to Equity (MRQ)
vs sector
1.77
13.74
Return on Investment (TTM)
vs sector
69.58
12.30
Return on Equity (TTM)
vs sector
78.68
13.41

EXECUTIVE LEADERSHIP

Lars Rasmussen
Chairman of the Board, Since 2018
Salary: kr.11,200,000.00
Bonus: kr.1,400,000.00
Kristian Villumsen
Chief Executive Officer, Member of the Executive Management, Since 2018
Salary: kr.5,900,000.00
Bonus: kr.700,000.00
Niels Louis-Hansen
Deputy Chairman of the Board, Since
Salary: --
Bonus: --
Anders Lonning-Skovgaard
Chief Financial Officer, Executive Vice President, Member of the Executive Management, Since 2014
Salary: kr.5,100,000.00
Bonus: kr.600,000.00
Allan Rasmussen
Executive Vice President, Global Operations; Member of the Executive Management, Since 2014
Salary: kr.4,700,000.00
Bonus: kr.600,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

Holtedam 1-3
HUMLEBAEK     3050

Phone:

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.

SPONSORED STORIES